Component

Etomoxir

Context-specific entity; species, compartment and exposure are stated on each claim.

3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. High etomoxir exposure depleted free CoA and inhibited IL-4 macrophage polarization even without Cpt1a or Cpt2 expression.

    Etomoxir → Mouse macrophage free CoA pool source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract and full-text genetic/pharmacologic experiments
    experimental_model
    Mouse macrophages; pharmacologic exposure exceeding concentrations needed to inhibit CPT1.
    limitations
    Etomoxiryl-CoA formation was the proposed depletion mechanism; not evidence that carnitine depletes CoA.
    nutrient_topic
    L-Carnitine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnitine
    plain_language
    The experiment exposed a CoA-related off-target effect.
    primary_references
    Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30043752/ · DOI 10.1016/j.cmet.2018.06.001

    L-Carnitine: synthesis, acyl-group transport, fuel selection and nutrient interactions (2026-09-19) · lines 450–456

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Mouse macrophages; pharmacologic exposure exceeding concentrations needed to inhibit CPT1. · source_derived_draft · unverified_draft

    ## l-carnitine-etomoxir-coa The experiment exposed a CoA-related off-target effect. High etomoxir exposure depleted free CoA and inhibited IL-4 macrophage polarization even without Cpt1a or Cpt2 expression. Model: Mouse macrophages; pharmacologic exposure exceeding concentrations needed to inhibit CPT1. Limitations: Etomoxiryl-CoA formation was the proposed depletion mechanism; not evidence that carnitine depletes CoA. Evidence access: Primary abstract and full-text genetic/pharmacologic experiments Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30043752/ · DOI 10.1016/j.cmet.2018.06.001
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Genetic loss of Cpt1a or Cpt2 did not reproduce the strong block of IL-4-driven macrophage polarization caused by high-dose etomoxir.

    Experimental context and source evidence
    evidence_access
    Primary abstract and full-text mouse macrophage methods
    experimental_model
    Mouse macrophage genetic and pharmacologic comparisons.
    limitations
    Context-specific immune result, not a statement that fatty-acid oxidation never matters.
    nutrient_topic
    L-Carnitine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnitine
    plain_language
    A drug effect did not prove that the carnitine shuttle was required.
    primary_references
    Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30043752/ · DOI 10.1016/j.cmet.2018.06.001

    L-Carnitine: synthesis, acyl-group transport, fuel selection and nutrient interactions (2026-09-19) · lines 442–448

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Mouse macrophage genetic and pharmacologic comparisons. · source_derived_draft · unverified_draft

    ## l-carnitine-macrophage-cpt-loss A drug effect did not prove that the carnitine shuttle was required. Genetic loss of Cpt1a or Cpt2 did not reproduce the strong block of IL-4-driven macrophage polarization caused by high-dose etomoxir. Model: Mouse macrophage genetic and pharmacologic comparisons. Limitations: Context-specific immune result, not a statement that fatty-acid oxidation never matters. Evidence access: Primary abstract and full-text mouse macrophage methods Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30043752/ · DOI 10.1016/j.cmet.2018.06.001
    Complete structured claim and evidence
  2. T-cell-specific Cpt1a deletion showed that the ACC2/Cpt1a pathway was largely dispensable for memory and regulatory T-cell formation in the tested models.

    Experimental context and source evidence
    evidence_access
    Primary abstract and full-text mouse genetic methods
    experimental_model
    Mouse T-cell conditional knockout and differentiation/infection experiments.
    limitations
    Does not exclude other tissue or immune contexts.
    nutrient_topic
    L-Carnitine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnitine
    plain_language
    Genetic tests limit broad claims about carnitine-shuttle dependence of immunity.
    primary_references
    Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30043753/ · DOI 10.1016/j.cmet.2018.06.002

    L-Carnitine: synthesis, acyl-group transport, fuel selection and nutrient interactions (2026-09-19) · lines 458–464

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Mouse T-cell conditional knockout and differentiation/infection experiments. · source_derived_draft · unverified_draft

    ## l-carnitine-tcell-cpt-loss Genetic tests limit broad claims about carnitine-shuttle dependence of immunity. T-cell-specific Cpt1a deletion showed that the ACC2/Cpt1a pathway was largely dispensable for memory and regulatory T-cell formation in the tested models. Model: Mouse T-cell conditional knockout and differentiation/infection experiments. Limitations: Does not exclude other tissue or immune contexts. Evidence access: Primary abstract and full-text mouse genetic methods Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30043753/ · DOI 10.1016/j.cmet.2018.06.002
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards